International Clinical Trial: Peritumoral and Periganglionic Infiltration of Levobupivacaine Prior to Conservative Surgery for Triple-negative Breast Cancer

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07458204) titled 'Peritumoral and Periganglionic Infiltration of Levobupivacaine Prior to Conservative Surgery for Triple-negative Breast Cancer' on March 3.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).

Primary Sponsor: Institut Jean-Godinot

Condition: Triple-negative Breast Cancer

Intervention: Drug: LVB infiltration

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: October 1, 2026

Target Sample Size: 760

Countries of Recruitment: France

To know more, visit https://clinical...